Biotechs such as Gilead (NASDAQ:GILD) and Vertex Pharma (NASDAQ:VRTX), with a high local tax bill, a heavy U.S.-based ...

Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its ...

Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a company (having a market cap of Rs 26,779.30 Crore) operating in Hospitals & Allied Services sector. Krishna Institute ...